Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38729566

Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2024 Aug
First author
Goetz MP

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2025 Dec;36(12):1556. doi: 10.1016/j.annonc.2025.07.002.
    note
    Source null
    related pmid
    41093689
    relationship
    Erratum in

Authors and identifiers

  1. name
    Goetz MP
    type
    Author
  2. name
    Toi M
    type
    Author
  3. name
    Huober J
    type
    Author
  4. name
    Sohn J
    type
    Author
  5. name
    Trédan O
    type
    Author
  6. name
    Park IH
    type
    Author
  7. name
    Campone M
    type
    Author
  8. name
    Chen SC
    type
    Author
  9. name
    Manso LM
    type
    Author
  10. name
    Paluch-Shimon S
    type
    Author
  11. name
    Freedman OC
    type
    Author
  12. name
    O'Shaughnessy J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Goetz MP
    type
    Author
  2. name
    Toi M
    type
    Author
  3. name
    Huober J
    type
    Author
  4. name
    Sohn J
    type
    Author
  5. name
    Trédan O
    type
    Author
  6. name
    Park IH
    type
    Author
  7. name
    Campone M
    type
    Author
  8. name
    Chen SC
    type
    Author
  9. name
    Manso LM
    type
    Author
  10. name
    Paluch-Shimon S
    type
    Author
  11. name
    Freedman OC
    type
    Author
  12. name
    O'Shaughnessy J
    type
    Author
bibliography ids
  1. nci-bib-55a0ed52725a368608607675
book metadata
content sha256
54993372cdcc4ffa4f95935926e511f094444926abe20c6ca7bf2be2929b7e02
document type
citation
dois
  1. 10.1016/j.annonc.2024.04.013
electronic publication date
display
2024 May 8
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:38729566
immutable id
pubmed:38729566@54993372cdcc4ffa4f95935926e511f094444926abe20c6ca7bf2be2929b7e02
journal
abbreviation
Ann Oncol
issn electronic
1569-8041
issn print
0923-7534
issue
8
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
718-727
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2025 Dec;36(12):1556. doi: 10.1016/j.annonc.2025.07.002.
    note
    Source null
    related pmid
    41093689
    relationship
    Erratum in
outcomes validated
false
pmid
38729566
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
5cf5641539c264e3301e0aa120a46f155f097d371b575c10e1761d43d7cf7d78
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Aug
precision
month
year
2024
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Multicenter Study
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38729566/
title
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.

Preserved source evidence · Not medical advice